The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ESH 2017 | AML immunotherapy: pre-clinical data to look forward to at ASH 2017
It is still early days for immunotherapeutic strategies. Speaking from the International Conference on Acute Myeloid Leukemia 2017, Estoril, Portugal by the European School of Hematology (ESH), Marion Subklewe, MD, of the University of Munich, Munich, Germany, discusses her interest in pre-clinical data and understanding the mechanism of action of immunotherapy in acute myeloid leukemia. Prof. Subklewe highlights the work on this subject to look forward to at the American Society of Hematology (ASH) 2017 congress.
